Get the Stockscreener App
1.92
2.67%
+0.05
After Hours:
1.8812
-0.0388
-2.02%
Lexicon Pharmaceuticals Inc Stock (LXRX) Forecast
The Lexicon Pharmaceuticals Inc (LXRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.8052, representing a -58.06% decrease from the current price of $1.92. The highest analyst price target is $1.5283, and the lowest is $0.0822.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LXRX Price Target
Average 1.7635
(-8.15% Downside)
Is Lexicon Pharmaceuticals Inc (LXRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.92 | Neutral |
| STOCH(9,6) | 64.05 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0311 | Buy |
| ADX(14) | 21.63 | Neutral |
| William %R | -18.52 | Sell |
| CCI(14) | 116.51 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.793
Buy
|
1.8044
Buy
|
| MA20 |
1.6985
Buy
|
1.8002
Buy
|
| MA50 |
2.0154
Sell
|
1.9116
Buy
|
| MA100 |
1.9913
Sell
|
1.9081
Buy
|
| MA200 |
1.6685
Buy
|
1.9331
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, LXRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 5 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on LXRX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.92 indicates that LXRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 64.05 indicates that LXRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that LXRX is oversold. This suggests that LXRX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.63 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 116.51 indicates that LXRX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term LXRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lexicon Pharmaceuticals Inc financial reports and earnings history, Lexicon Pharmaceuticals Inc (LXRX) stock could reach $4.3157 by 2030, $3.7797 by 2040 and $12.46 by 2050. See the projected annual prices until 2050 of the Lexicon Pharmaceuticals Inc stock below:
- Lexicon Pharmaceuticals Inc (LXRX) is expected to reach an average price of $2.0913 in 2035, with a high prediction of $2.0657 and a low estimate of $2.0946. This indicates an $8.92% rise from the last recorded price of $1.92.
- Lexicon Pharmaceuticals Inc (LXRX) stock is projected to chart a bullish course in 2040, with an average price target of $3.7723, representing an $96.48% surge from its current level. The forecast ranges from a conservative $3.7865 to a sky-high $3.7797.
- Our analysts predict Lexicon Pharmaceuticals Inc (LXRX) to jump 298.34% by 2045, soaring from $7.5546 to an average price of $7.6481, potentially reaching $7.4424. While $7.5546 is the low estimate, the potential upside is significant.
- Lexicon Pharmaceuticals Inc (LXRX) stock is expected to climb by 2050, reaching an average of $12.38, a $545.03% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.46 and $12.62, respectively, highlighting the market's uncertainty.
Lexicon Pharmaceuticals Inc Stock (LXRX) Year by Year Forecast
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2024
Our forecast for LXRX stock price in 2024 now indicates an average price target of $1.9061 with a high forecast of $3.73 and a low forecast of $0.0822. The average prediction reflects an decrease of -0.72% from the last recorded price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.2413 | $0.0822 | $1.5283 | -35.35% |
| July, 2024 | $3.5735 | $0.2235 | $2.4235 | +86.12% |
| August, 2024 | $3.5663 | $3.5713 | $3.5204 | +85.75% |
| September, 2024 | $1.249 | $2.4691 | $3.5083 | -34.95% |
| October, 2024 | $1.5389 | $1.547 | $1.4931 | -19.85% |
| November, 2024 | $1.1718 | $1.0148 | $0.7948 | -38.97% |
| December, 2024 | $0.2054 | $1.1926 | $0.9287 | -89.30% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2025
Lexicon Pharmaceuticals Inc Stock (LXRX) is expected to reach an average price of $1.3074 in 2025, with a high prediction of $2.6083 and a low estimate of $0.00655. This indicates an -31.90% fall from the last recorded price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.6294 | $0.00655 | $0.6934 | -67.22% |
| February, 2025 | $1.4372 | $0.6533 | $1.1122 | -25.15% |
| March, 2025 | $1.78 | $1.4592 | $1.48 | -7.29% |
| April, 2025 | $2.4498 | $2.187 | $2.3348 | +27.60% |
| May, 2025 | $2.4377 | $2.4957 | $2.4737 | +26.96% |
| June, 2025 | $2.4305 | $2.4605 | $2.3866 | +26.59% |
| July, 2025 | $2.2803 | $2.3974 | $2.2714 | +18.76% |
| August, 2025 | $2.2531 | $2.2585 | $2.2131 | +17.35% |
| September, 2025 | $2.3009 | $2.3109 | $2.1509 | +19.84% |
| October, 2025 | $2.4757 | $2.3279 | $2.3088 | +28.94% |
| November, 2025 | $2.5835 | $2.4996 | $2.4127 | +34.56% |
| December, 2025 | $2.8483 | $2.5644 | $2.6083 | +48.35% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2026
The predicted value for Lexicon Pharmaceuticals Inc (LXRX) in 2026 is set at an average of $2.9499. Estimates vary from a peak of $5.8873 to a trough of $0.0125, indicating an +53.64% surge from the present price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.2862 | $2.4712 | $2.7903 | +19.07% |
| February, 2026 | $0.474 | $1.054 | $2.2731 | -75.31% |
| March, 2026 | $3.0682 | $0.0618 | $5.5982 | +59.80% |
| April, 2026 | $3.9834 | $3.2412 | $5.8873 | +107.47% |
| May, 2026 | $3.0056 | $2.2795 | $4.4164 | +56.54% |
| June, 2026 | $1.7377 | $1.6877 | $3.0786 | -9.49% |
| July, 2026 | $0.7629 | $0.5429 | $2.0269 | -60.26% |
| August, 2026 | $1.3551 | $0.519 | $1.5951 | -29.42% |
| September, 2026 | $0.6303 | $0.2303 | $2.5712 | -67.17% |
| October, 2026 | $0.1725 | $0.0125 | $0.6834 | -91.02% |
| November, 2026 | $1.3747 | $0.0614 | $1.6747 | -28.40% |
| December, 2026 | $1.5399 | $1.0938 | $2.1299 | -19.80% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lexicon Pharmaceuticals Inc (LXRX) is $1.5591, with a high forecast of $3.0889 and a low forecast of $0.0293. This indicates an -18.80% decrease from the last price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.8621 | $1.4079 | $3.0889 | -3.02% |
| February, 2027 | $1.7842 | $1.5281 | $2.5871 | -7.07% |
| March, 2027 | $0.7594 | $0.6094 | $2.0573 | -60.45% |
| April, 2027 | $0.3916 | $0.2116 | $1.6345 | -79.60% |
| May, 2027 | $0.0338 | $0.0293 | $0.4446 | -98.24% |
| June, 2027 | $0.811 | $0.0332 | $0.621 | -57.76% |
| July, 2027 | $0.7988 | $0.8119 | $0.748 | -58.39% |
| August, 2027 | $0.8367 | $0.5697 | $0.6258 | -56.42% |
| September, 2027 | $1.0315 | $1.0286 | $0.9845 | -46.28% |
| October, 2027 | $1.2593 | $1.0284 | $1.1793 | -34.41% |
| November, 2027 | $0.2029 | $0.7906 | $0.6302 | -89.43% |
| December, 2027 | $0.5681 | $0.0741 | $0.6681 | -70.41% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2028
In 2028, Lexicon Pharmaceuticals Inc (LXRX) is projected to reach an average price of $0.8763, with a high projection of $1.7479 and a low estimate of $0.00459. This indicates an -54.36% fall from the last price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1703 | $0.0822 | $0.8911 | -91.13% |
| February, 2028 | $0.0976 | $0.0133 | $0.4233 | -94.92% |
| March, 2028 | $0.2823 | $0.2145 | $0.2454 | -85.29% |
| April, 2028 | $0.2502 | $0.2132 | $0.1502 | -86.97% |
| May, 2028 | $0.365 | $0.2541 | $0.235 | -80.99% |
| June, 2028 | $0.0572 | $0.0628 | $0.3119 | -97.02% |
| July, 2028 | $0.0694 | $0.0237 | $0.2713 | -96.39% |
| August, 2028 | $0.0646 | $0.00459 | $0.7546 | -96.64% |
| September, 2028 | $0.2768 | $0.0407 | $0.4068 | -85.59% |
| October, 2028 | $1.4489 | $0.2375 | $1.7479 | -24.53% |
| November, 2028 | $0.7691 | $0.5741 | $1.542 | -59.94% |
| December, 2028 | $0.3663 | $0.1563 | $1.1522 | -80.92% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2029
The 2029 price forecast for Lexicon Pharmaceuticals Inc Stock (LXRX) is $1.4542 on average, with a high prediction of $2.89 and a low estimate of $0.0185. This represents an -24.26% decrease from the previous price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1515 | $0.0185 | $0.4824 | -92.11% |
| February, 2029 | $0.0237 | $0.1104 | $0.1546 | -98.77% |
| March, 2029 | $0.3541 | $0.0733 | $0.1391 | -81.56% |
| April, 2029 | $0.512 | $0.6761 | $0.6158 | -73.34% |
| May, 2029 | $0.6267 | $0.4448 | $0.4659 | -67.36% |
| June, 2029 | $0.4346 | $0.5307 | $0.4376 | -77.37% |
| July, 2029 | $0.00241 | $0.2124 | $0.2415 | -99.87% |
| August, 2029 | $0.4028 | $0.0794 | $0.5028 | -79.02% |
| September, 2029 | $1.125 | $0.3958 | $2.3019 | -41.41% |
| October, 2029 | $0.9102 | $0.7141 | $1.4662 | -52.59% |
| November, 2029 | $0.3524 | $0.3024 | $1.1332 | -81.65% |
| December, 2029 | $3.43 | $0.2084 | $2.89 | +78.65% |
Lexicon Pharmaceuticals Inc Stock (LXRX) Price Forecast for 2030
Lexicon Pharmaceuticals Inc Stock (LXRX) is expected to reach an average price of $6.1061 in 2030, with a high forecast of $8.4309 and a low forecast of $3.7813. This signifies an +218.03% surge from the last price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3896 | $4.0439 | $4.3157 | +128.62% |
| February, 2030 | $3.7152 | $3.7813 | $3.7274 | +93.50% |
| March, 2030 | $8.6259 | $4.6891 | $8.4309 | +349.27% |
| April, 2030 | $8.3966 | $8.4426 | $8.3666 | +337.32% |
| May, 2030 | $6.5896 | $6.7422 | $8.2505 | +243.21% |
| June, 2030 | $5.6018 | $6.314 | $6.1179 | +191.76% |
| July, 2030 | $5.5014 | $5.7296 | $5.6174 | +186.53% |
| August, 2030 | $4.752 | $4.6431 | $5.3553 | +147.50% |
| September, 2030 | $5.1277 | $5.1448 | $4.9427 | +167.07% |
| October, 2030 | $6.1022 | $5.2116 | $5.7322 | +217.83% |
| November, 2030 | $6.9279 | $6.3262 | $6.5979 | +260.83% |
| December, 2030 | $7.0424 | $7.0057 | $6.8436 | +266.79% |
1.06%
1.27%
Cap:
|
Volume (24h):